NCT02006914|CompletedDMC
Loading search results
Sponsor study identifier
observational
47
1 country
1
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2010
Actual (reported)Study Completion
April 2012
Actual (reported)This research is to investigate the nutritional supplement chromium picolinate. The investigators are testing to see how effective this supplement is in treating insulin resistance associated with HIV disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
May 2010
Actual (reported)August 11, 2011
Actual (reported)April 2012
Actual (reported)December 10, 2013
Actual (reported)Chromium Picolinate supplementation
Hypothesis that chromium picolinate improved insulin-stimulated glucose uptake by increasing the insulin receptor-mediated tyrosine phosphorylation of insulin receptor substrate-1, resulting in increased association with phosphatidylinositol 3-kinase. There was a significant negative correlation between the fasting glucose levels and the insulin sensitivity.
8 weeks
Subjects who are HIV+ and insulin resistant
HIV+ and insulin resistant
Subjects will be asked to take chromium picolinate; 2 tablets per day, 1000 mcg or a placebo for a total of 8 weeks.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Anyone with a positive diagnosis of HIV disease.
Stony Brook University Hospital GCRC
Stony Brook, New York, 11794, United States
Stein SA, Mc Nurlan M, Phillips BT, Messina C, Mynarcik D, Gelato M. Chromium Therapy for Insulin Resistance Associated with HIV-Disease. J AIDS Clin Res. 2013 Sep 7;4(9):239. doi: 10.4172/2155-6113.1000239.
Fat and muscle biopsy samples
Marie C Gelato, MD, PhD
Stony Brook University School of Medicine Dept. Of Medicine/Endocrinology
47 participants (actual enrollment reported by the registry).
First Submitted
August 11, 2011
First Posted
December 10, 2013
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
Chromium Picolinate for the Treatment of Metabolic Syndrome
Contact the study team to confirm eligibility.
Primary Completion
May 2010
Actual (reported)Study Completion
April 2012
Actual (reported)Last Updated
December 10, 2013
Record last verified: 2013-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: